表紙
市場調查報告書

產前診斷的全球市場

Prenatal Diagnostics

出版商 Global Industry Analysts, Inc. 商品編碼 248920
出版日期 內容資訊 英文 182 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
產前診斷的全球市場 Prenatal Diagnostics
出版日期: 2019年05月01日內容資訊: 英文 182 Pages
簡介

本報告提供全球產前診斷市場相關調查分析,各產品區隔,各地區 (美國、加拿大、日本、歐洲、亞太地區、南美、其他) ,市場成果與預測,主要企業簡介等系統性資訊。

第1章 簡介,調查手法,產品定義

第2章 產業概要

  • 產前檢查:簡介
  • 產前基因檢測的理論的根據
  • 產前檢查今後數年將踏實成長
  • 先進地區
  • 發展中地區的急速成長預測等

第3章 市場趨勢,成長促進因素,問題點

  • 非侵入性產前檢查 (NIPT) 改變產前檢查形勢
  • 影響NIPT的普及的主要原因
  • NIPT排除傳統的風險與不確定性
  • 代替篩檢檢驗:NIPT可能的變化
  • NIPT利用的多樣性等

第4章 產品概要

  • 產前檢查
  • 建議進行產前檢查時的疑慮要素
  • 產前檢查的類型
  • 產前篩檢檢驗
  • 產前診斷檢驗
  • 主要技術

第5章 競爭情形

  • 全球主要企業
    • ANGLE Plc (英國)
    • Berry Genomics Co., Ltd. (中國)
    • BGI Genomics (丹麥)
    • F. Hoffmann-La Roche Ltd. (瑞士)
    • Hologic, Inc. (美國)
    • Illumina, Inc. (美國)
    • Laboratory Corporation of America® Holdings (美國)
    • Sequenom, Inc. (美國)
    • Lifecodexx AG (德國)
    • Natera, Inc. (美國)
    • Quest Diagnostics, Inc. (美國)
    • Ravgen, Inc. (美國)
  • 產品的認證/銷售
  • 近來產業活動

第6章 全球市場預測

第7章 各地區市場預測

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 南美
  • 其他

第8章 企業簡介

  • 企業簡介:43家公司 (包含事業部/子公司的話44家)
    • 美國
    • 歐洲
    • 亞太地區 (日本以外)
    • 中東

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-7675

This report analyzes the worldwide markets for Prenatal Diagnostics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 43 companies including many key and niche players such as -

ANGLE Plc
Berry Genomics Co., Ltd.
BGI Genomics
F. Hoffmann-La Roche Ltd.
Hologic, Inc.
Illumina, Inc.

Table of Contents

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Data Interpretation & Reporting Level
  • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
  • Prenatal Testing
    • Prenatal Screening Tests
    • Prenatal Diagnostic Tests
      • Non-Invasive Prenatal Diagnostic Tests

2. INDUSTRY OVERVIEW

  • Prenatal Testing: An Introductory Prelude
  • The Rationale for Prenatal Genetic Testing
  • Steady Growth Projected Over the Coming Years for Prenatal Testing
  • Developed Regions: Primary Revenue Contributors
    • Table 1: Developed Regions Account for Lion's Share of World Prenatal Diagnostics Market: Percentage Breakdown of Revenues for Developed and Developing Regions (2018E & 2022P) (includes corresponding Graph/Chart)
  • Fast Paced Growth Forecasts in Developing Regions
    • Table 2: Global Prenatal Diagnostics Market - Geographic Regions Ranked by CAGR (Revenues) for 2015-2022: Asia-Pacific, Latin America, Rest of World, Canada, Europe, US and Japan (includes corresponding Graph/Chart)
  • Northbound Trajectory in Healthcare Spending Creates Conducive Environment
    • Table 3: Global Pharmaceutical R&D Spending (in US$ Billion) for the Years 2010 through 2017 (includes corresponding Graph/Chart)
    • Table 4: Leading Countries with Highest Healthcare Spending as a Percentage (%) of GDP (2016) (includes corresponding Graph/Chart)
    • Table 5: Per Capita Healthcare Spending (in US$) in Select Countries for the Year 2016 (includes corresponding Graph/Chart)
  • Prevailing Economic Scenario Favors Increased Healthcare Spending
    • Table 6: World Real GDP Growth Rates in % (2016-2019P): Breakdown by Country/Region (includes corresponding Graph/Chart)
  • Progressive Momentum in Med Tech Sector Generates Parallel Opportunities

3. MARKET TRENDS, GROWTH DRIVERS & ISSUES

  • Non-Invasive Prenatal Testing (NIPT) Transforms Prenatal Testing Landscape
  • Major Factors Influencing Penetration of NIPT
    • Table 7: Price Comparison of Existing Tests and Screening Procedures for Down's Syndrome
  • NIPT Eliminates Risks & Uncertainty of Conventional Procedures
  • Replacing Screening Tests - A More Conceivable Change through NIPT
  • Diversity in NIPT Usage on the Cards
  • Benefits Outweigh Snags in NIPT Tests
  • Whole Genome Sequencing Technology in NIPT
  • DNA - More Ideal Target for NIPT Analysis than Whole Cells
  • Conventional Invasive Techniques Loose Sheen
  • Chromosomal Abnormalities Lead the Prenatal Testing Space
  • Chromosomal Abnormalities - A Substantial Economic Burden
    • List of Genetic Disorders by Event, Genetic Manifestation and Prevalence
  • Significant Opportunities in Down's Syndrome Testing
  • List of Select Screening Tests Available for T21 Screening and Confirmation
  • Beyond Down's Syndrome - Need to Test Additional Targets Crucial
  • Trisomy 18 or Edward's Syndrome
  • Trisomy 13 or Patau Syndrome
  • Cystic Fibrosis Screening and Diagnosis
    • Cystic Fibrosis Screening Market - Highly Fragmented
    • ACOG and ACGM Recommendations Boost Demand for Prenatal CF Testing
  • Prenatal Testing Crucial to Detect Risk of Huntington's Disease
  • Increasing Congenital Disorder Incidence - Key Driver for Prenatal Diagnostics
  • Prenatal Testing - Effective Way of Alleviating Syphilis Related Deaths and Stillbirths
  • Molecular Diagnostics Widen Scope & Span of Prenatal Testing
  • NGS & MPS - Enabling Shorter Time to Test Results
  • Microarray-Based Prenatal Testing Gathers Steam
  • Sequencing in Prenatal Testing - A Potential High Growth Market
  • Ultrasound - An Indispensable Combination with Blood Based Screening Tests
  • New Sub-Targets on the Anvil for Ultrasound-Based Screening
  • Counseling - An Imperative Measure Before and After Prenatal Testing
  • Role of Prenatal Testing in Managing Preterm Births
  • Lower Sensitivity & Specificity of Existing Tests - A Case for New Tests on the Anvil
    • Table 8: List of Available Prenatal Screening/ Diagnostic Tests by Accuracy
  • High Sensitivity Serum Tests May Not Have Many Takers
  • Ballooning Global Female Population Offers Increased Growth Opportunities
    • Table 9: Percentage Share of Female Population in the Age Group (15-54) by Country: 2015
  • Issues & Challenges
  • Prenatal Diagnostics: Treading Sensitive Ethical Issues
  • Controversy Related to "Incidental Findings" of Prenatal Tests
  • Opposition to NIPT Technique - A Significant Hurdle to Adoption
  • Unresolved Issues Hamper Widespread Testing for Monogenetic Disease
  • Dearth of Genetic Counselors - A Major Hurdle for Genetic Testing

4. PRODUCT OVERVIEW

  • Prenatal Testing
  • Factors Considered for Recommending Prenatal Tests
  • Types of Prenatal Testing
  • Prenatal Screening Tests
    • Evolution of Screening Tests
    • Ultrasound
      • Types of Ultrasound
      • Ultrasound Examination Types and Use in Prenatal Screening of Fetus
    • Triple Screen Test
    • Quad Screen Test
  • Prenatal Diagnostic Tests
    • Chorionic Villus Sampling
      • The Procedure
      • Risks
    • Amniocentesis
      • The Procedure
      • Risks
    • Cordocentesis
      • Procedure
      • Risks
    • Overview of Current Analysis Methods for Invasive Tests
      • Comparison of Competitive Technologies Employed in Invasive Prenatal Diagnosis
  • Major Technologies Used in Analyzing Invasive Procedure-Derived Samples
    • Karyotyping
    • Fluorescence In Situ Hybridization (FISH)
    • Digital PCR - Entering the Realm of Fetal Aneuploidy Detection
      • Lower Fetal DNA Percentage Stifles Progression in Digital PCR Utility Research
      • Non-Invasive Prenatal Diagnostic Tests
      • A Review of Prenatal Screening & Diagnostic Testing Methods

5. COMPETITIVE LANDSCAPE

  • Leading Players in the World Prenatal Diagnostics Market
  • Competition Intensifies in the NIPT Vertical
  • Select Companies Marketing/Developing NIPT Tests
  • Sequenom - A Major Player in the Non-Invasive Test Space
    • Overview of Sequenom NIPT Tests
      • MaterniT21(tm)
      • SensiGene Fetal RhD
      • Sequenom's Prenatal Diagnostics Portfolio in a Nutshell
  • Patent Wars in the NIPT Space
  • The Changing Regulatory Paradigm of LDT
  • Verifi(tm) Becomes the First Commercial Test in the Landscape of LDTs
  • M&A Activity
  • Select M&A Deals in the Prenatal Testing Market (2013-2018)
  • 5.1 Focus on Select Global Players
  • ANGLE Plc (UK)
  • Berry Genomics Co., Ltd. (China)
  • BGI Genomics (Denmark)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Hologic, Inc. (USA)
  • Illumina, Inc. (USA)
  • Laboratory Corporation of America(r) Holdings (USA)
  • Sequenom, Inc. (USA)
  • Lifecodexx AG (Germany)
  • Natera, Inc. (USA)
  • Quest Diagnostics, Inc. (USA)
  • Ravgen, Inc. (USA)
  • 5.2 Product Approvals/Launches
  • Angle Achieves Positive Results for Parsortix in NIPT
  • Counsyl Bags Regulatory Approval for Counsyl Prelude(tm) Prenatal Screen in New York
  • BGI Receives Thai FDA's Import Certificate for BGISEQ-500 and NIFTY Kit
  • Illumina Receives CE Mark for Expanded VeriSeq NIPT Analysis Software in EU
  • Baylor Genetics Introduces PreSeek(tm) Non-Invasive Prenatal Multi-Gene Sequencing Screen
  • BGI Bags CE Certification for NIFTY(r) Test Kit for Fetal Chromosome Aneuploidy
  • 5.3 Recent Industry Activity
  • Myriad Genetics Snaps Up Counsyl
  • Berry Genomics and Prenetics to Establish Joint Venture Firm
  • 10x Genomics Teams Up with Berry Genomics
  • Illumina Inks NIPT Deal with Harvard Pilgrim Health Care
  • Konica Minolta Establishes Konica Minolta Precision Medicine
  • ANGLE Teams Up with QIAGEN NV
  • BGI Collaborates with Lunenfeld-Tanenbaum Research Institute
  • Illumina Leads the Launch of CAPS
  • Progenity Bags New Funding
  • Konica Minolta Acquires Ambry Genetics
  • Eurofins Scientific Acquires GATC Biotech
  • LifeCodexx Teams Up with LifeCell in India

6. GLOBAL MARKET PERSPECTIVE

    • Table 10: World Recent Past, Current & Future Analysis for Prenatal Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 11: World Historic Review for Prenatal Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 12: World 14-Year Perspective for Prenatal Diagnostics by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

7. REGIONAL MARKET PERSPECTIVE

  • 7.1 The United States
  • A. Market Analysis
    • The United States: Prime Market for Prenatal Diagnostics
    • Table 13: US Prenatal Diagnostics Market by End-Use Segment (2018E): Percentage Breakdown of Revenues for Clinics, Hospitals, and Others (includes corresponding Graph/Chart)
    • Table 14: US Prenatal Diagnostics Market by Technology (2018E): Percentage Breakdown of Revenues for Diagnostic and Screening (includes corresponding Graph/Chart)
    • Popularity of Screening & ACOG Guidelines Sink Invasive Prenatal Diagnosis Volumes
    • Leading NIPT Vendors
  • B. Market Analytics
    • Table 15: The US Recent Past, Current & Future Analysis for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 16: The US Historic Review for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
  • 7.2 Canada
  • Market Analysis
    • Table 17: Canadian Recent Past, Current & Future Analysis for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 18: Canadian Historic Review for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
  • 7.3 Japan
  • Market Analysis
    • Table 19: Japanese Recent Past, Current & Future Analysis for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 20: Japanese Historic Review for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
  • 7.4 Europe
  • Market Analysis
    • Table 21: European Recent Past, Current & Future Analysis for Prenatal Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 22: European Historic Review for Prenatal Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 23: European 14-Year Perspective for Prenatal Diagnostics by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
  • 7.4.1 France
  • Market Analysis
    • Table 24: French Recent Past, Current & Future Analysis for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 25: French Historic Review for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
  • 7.4.2 Germany
  • Market Analysis
    • Table 26: German Recent Past, Current & Future Analysis for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 27: German Historic Review for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
  • 7.4.3 Italy
  • Market Analysis
    • Table 28: Italian Recent Past, Current & Future Analysis for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 29: Italian Historic Review for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
  • 7.4.4 The United Kingdom
  • A. Market Analysis
    • Prospects Remain Positive for Prenatal Testing
    • Table 30: UK Non-Invasive Prenatal Testing Market by Gestation Period (2018E): Percentage Breakdown of Revenues for 0-12 Weeks, 13-24 Weeks, and 25-36 Weeks (includes corresponding Graph/Chart)
    • Increasing Need for Less Risky Prenatal Diagnostic Methods in the UK
  • B. Market Analytics
    • Table 31: The UK Recent Past, Current & Future Analysis for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 32: The UK Historic Review for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
  • 7.4.5 Spain
  • Market Analysis
    • Table 33: Spanish Recent Past, Current & Future Analysis for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 34: Spanish Historic Review for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
  • 7.4.6 Russia
  • Market Analysis
    • Table 35: Russian Recent Past, Current & Future Analysis for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 36: Russian Historic Review for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
  • 7.4.7 Rest of Europe
  • Market Analysis
    • Table 37: Rest of Europe Recent Past, Current & Future Analysis for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 38: Rest of Europe Historic Review for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
  • 7.5 Asia-Pacific
  • A. Market Analysis
    • Asia-Pacific Emerges as Fastest Growing Market for Prenatal Testing
    • Uptrend in IVD Sales Augurs Well for Market Growth
  • B. Market Analytics
    • Table 39: Asia-Pacific Recent Past, Current & Future Analysis for Prenatal Diagnostics by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 40: Asia-Pacific Historic Review for Prenatal Diagnostics by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 41: Asia-Pacific14-Year Perspective for Prenatal Diagnostics by Geographic Region - Percentage Breakdown of Dollar Sales for China, India, and Rest of Asia-Pacific Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
  • 7.5.1 China
  • A. Market Analysis
    • Prenatal Testing Makes Robust Inroads into the Vast Chinese Market
    • Laboratory Equipment & Supplies Sector in China: An Overview
  • B. Market Analytics
    • Table 42: Chinese Recent Past, Current & Future Analysis for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 43: Chinese Historic Review for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
  • 7.5.2 India
  • A. Market Analysis
    • Potential Opportunities for Prenatal Testing in India
    • Indian Lab Equipment & Supplies Market: An Overview
  • B. Market Analytics
    • Table 44: Indian Recent Past, Current & Future Analysis for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 45: Indian Historic Review for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
  • 7.5.3 Rest of Asia-Pacific
  • Market Analysis
    • Table 46: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 47: Rest of Asia-Pacific Historic Review for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
  • 7.6 Latin America
  • Market Analysis
    • Table 48: Latin American Recent Past, Current & Future Analysis for Prenatal Diagnostics by Geographic Region - Brazil, and Rest of Latin American Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 49: Latin American Historic Review for Prenatal Diagnostics by Geographic Region - Brazil, and Rest of Latin American Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 50: Latin American 14-Year Perspective for Prenatal Diagnostics by Geographic Region - Percentage Breakdown of Dollar Sales for Brazil, and Rest of Latin American Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
  • 7.6.1 Brazil
  • Market Analysis
    • Table 51: Brazilian Recent Past, Current & Future Analysis for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 52: Brazilian Historic Review for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
  • 7.6.2 Rest of Latin America
  • Market Analysis
    • Table 53: Rest of Latin American Recent Past, Current & Future Analysis for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 54: Rest of Latin American Historic Review for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
  • 7.7 Rest of World
  • Market Analysis
    • Table 55: Rest of World Recent Past, Current & Future Analysis for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 56: Rest of World Historic Review for Prenatal Diagnostics Market with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

8. COMPANY PROFILES

  • Total Companies Profiled: 43 (including Divisions/Subsidiaries - 44) The United States (19) Europe (17) - France (1) - Germany (2) - The United Kingdom (4) - Spain (1) - Rest of Europe (9) Asia-Pacific (Excluding Japan) (6) Middle-East (2) PRENATAL DIAGNOSTICS MCP-7675 CONTENTS
Back to Top